“Anemia and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients”

References

• Cella D. Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol. 1998;25:43–46.
   PubMed Web of Science ®Google Scholar
• Gilreath JA, Stenehjem DD, Rodgers GM. Diagnosis and treatment of cancer-related anemia. Am J Hematol. 2014;89:203–212. doi:10.1002/ajh.23628.
   PubMed Web of Science ®Google Scholar
• Madeddu C, Gramignano G, Astara G, Demontis R, Sanna E, Atzeni V, et al. Pathogenesis and treatment options of cancer related anemia: perspective for a targeted mechanism-based approach. Front Physiol. 2018;9:1294.
   PubMed Web of Science ®Google Scholar
• Cybulska P, Goss C, Tew WP, Parameswaran R, Sonoda Y. Indications for and complications of transfusion and the management of gynecologic malignancies. Gynecol Oncol. 2017;146(2):416–426. doi:10.1016/j.ygyno.2017.05.010.
   PubMed Web of Science ®Google Scholar
• Cybulska P, Goss C, Tew WP, Parameswaran R, Sonoda Y. Corrigendum to "Indications for and complications of transfusion and the management of gynecologic malignancies" [Gynecol. Oncol. 146 (2017) 416-426]. Gynecol Oncol. 2018;148(1):235. doi:10.1016/j.ygyno.2017.11.030.
   PubMed Web of Science ®Google Scholar
• Gaspar BL, Sharma P, Das R. Anemia in malignancies: pathogenetic and diagnostic considerations. Hematology. 2015;20:18–25. doi:10.1179/1607845414Y.0000000161.
   PubMed Web of Science ®Google Scholar
• Kenar G, Koksoy EB, Urun Y, Utkan G. Prevalence, etiology and risk factors of anemia in patients with newly diagnosed cancer. Support Care Cancer. 2020;28(11):5235–5242. doi:10.1007/s00520-020-05336-w.
   PubMed Web of Science ®Google Scholar
• Knight K, Wade S, Balducci L. Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med. 2004;116(7):11–26S. doi:10.1016/j.amjmed.2003.12.008.
   PubMed Web of Science ®Google Scholar
• Hu K, Harrison LB. Impact of anemia in patients with head and neck cancer treated with radiation therapy. Curr Treat Options Oncol. 2005;6:31–45. doi:10.1007/s11864-005-0011-4.
   PubMedGoogle Scholar
• Choi YS, Yi CM, Sin JI, Ye GW, Shin IH, Lee TS. Impact of hemoglobin on survival of cervical carcinoma patients treated with concurrent chemoradiotherapy is dependent on lymph node metastasis findings by magnetic resonance imaging. Int J Gynecol Cancer. 2006;16(5):1846–1854. doi:10.1111/j.1525-1438.2006.00666.x.
   PubMed Web of Science ®Google Scholar
• Grogan M, Thomas GM, Melamed I, Wong FL, Pearcey RG, Joseph PK, et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer. 1999;86(8):1528–1536. doi:10.1002/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E.
   PubMed Web of Science ®Google Scholar
• Dunphy EP, Petersen IA, Cox RS, Bagshaw MA. The influence of initial hemoglobin and blood pressure levels on results of radiation therapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1989;16:1173–1178. doi:10.1016/0360-3016(89)90277-0.
   PubMed Web of Science ®Google Scholar
• Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001;91(12):2214–2221. doi:10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P.
   PubMed Web of Science ®Google Scholar
• Kandemir EG, Mayadagli A, Turken O, Yaylaci M, Ozturk A. Pre-treatment haemoglobin concentration is a prognostic factor in patients with early-stage breast cancer. J Int Med Res. 2005;33(3):319–328. doi:10.1177/147323000503300307.
   PubMed Web of Science ®Google Scholar
• Henke M, Sindlinger F, Ikenberg H, Gerds T, Schumacher M. Blood hemoglobin level and treatment outcome of early breast cancer. Strahlenther Onkol. 2004;180:45–51. doi:10.1007/s00066-004-1123-7.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen Y, Chen D, Jiang Y, Huang W, Ouyang H, et al. Impact of preoperative anemia on relapse and survival in breast cancer patients. BMC Cancer. 2014;14(1):844. doi:10.1186/1471-2407-14-844.
   PubMedGoogle Scholar
• Boehm DU, Lebrecht A, Schmidt M, Siggelkow W, Lindner C, Litz A, et al. Prognostic impact of haemoglobin levels in breast cancer. Anticancer Res. 2007;27:1223–1226.
   PubMed Web of Science ®Google Scholar
• Bottini A, Berruti A, Brizzi MP, Bersiga A, Generali D, Allevi G, et al. Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer. Br J Cancer. 2003;89(6):977–982. doi:10.1038/sj.bjc.6601216.
   PubMed Web of Science ®Google Scholar
• Zhu W, Xu B. Association of pretreatment anemia with pathological response and survival of breast cancer patients treated with neoadjuvant chemotherapy: a population-based study. PLoS One. 2015;10(8):e0136268. doi:10.1371/journal.pone.0136268.
   PubMed Web of Science ®Google Scholar
• Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28:2784–2795. doi:10.1200/JCO.2009.25.6529.
   PubMed Web of Science ®Google Scholar
• Crawford J, Cella D, Cleeland CS, Cremieux PY, Demetri GD, Sarokhan BJ, et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer. 2002;95(4):888–895. doi:10.1002/cncr.10763.
   PubMed Web of Science ®Google Scholar
• Obermair A, Handisurya A, Kaider A, Sevelda P, KLbl H, Gitsch G. The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review. Cancer. 1998;83(4):726–731. doi:10.1002/(SICI)1097-0142(19980815)83:4<726::AID-CNCR14>3.0.CO;2-U.
   PubMed Web of Science ®Google Scholar
• Shin NR, Lee YY, Kim SH, Choi CH, Kim TJ, Lee JW. Prognostic value of pretreatment hemoglobin level in patients with early cervical cancer. Obstet Gynecol Sci. 2014;57:28–36. doi:10.5468/ogs.2014.57.1.28.
   PubMedGoogle Scholar
• An MS, Yoo JH, Kim KH, Bae KB, Choi CS, Hwang JW, et al. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy. World J Surg Onc. 2015;13(1):64. doi:10.1186/s12957-015-0488-7.
   PubMedGoogle Scholar
• Chamogeorgakis T, Anagnostopoulos C, Kostopanagiotou G, Bhora F, Toumpoulis I, Georgiannakis E, et al. Does anemia affect outcome after lobectomy or pneumonectomy in early stage lung cancer patients who have not received neo-adjuvant treatment? Thorac Cardiovasc Surg. 2008;56(3):148–153. doi:10.1055/s-2007-989455.
   PubMed Web of Science ®Google Scholar
• Peters-Engl C, Cassik P, Schmidt I, Denison U, Medl M, Pokieser W, et al. Impact of haemoglobin levels during adjuvant chemotherapy on the survival of patients with primary breast cancer. Acta Oncol. 2005;44:129–133. doi:10.1080/02841860510007530.
   PubMed Web of Science ®Google Scholar
• Dubsky P, Sevelda P, Jakesz R, Hausmaninger H, Samonigg H, Seifert M, et al. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy. Clin Cancer Res. 2008;14(7):2082–2087. doi:10.1158/1078-0432.CCR-07-2068.
   PubMed Web of Science ®Google Scholar
• Fuso L, Mazzola S, Marocco F, Ferrero A, Dompe D, Carus AP, et al. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report. Gynecol Oncol. 2005;99(3):S187–S191. doi:10.1016/j.ygyno.2005.07.079.
   PubMed Web of Science ®Google Scholar
• Thomas G. The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience. Semin Oncol. 2001;28:60–65. doi:10.1016/S0093-7754(01)90215-5.
   PubMed Web of Science ®Google Scholar
• Zhang LL, Zhou GQ, Li YY, Tang LL, Mao YP, Lin AH, et al. Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a large-scale retrospective study. Cancer Med. 2017;6(12):2822–2831. doi:10.1002/cam4.1233.
   PubMed Web of Science ®Google Scholar
• Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist. 2002;7:492–508. doi:10.1634/theoncologist.7-6-492.
   PubMed Web of Science ®Google Scholar
• Harrison L, Blackwell K. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist. 2004;9(S5):31–40. doi:10.1634/theoncologist.9-90005-31.
   PubMed Web of Science ®Google Scholar
• Cosse JP, Michiels C. Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression. Anticancer Agents Med Chem. 2008;8:790–797. doi:10.2174/187152008785914798.
   PubMed Web of Science ®Google Scholar
• Wu HM, Jiang ZF, Ding PS, Shao LJ, Liu RY. Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells. Sci Rep. 2015;5:12291. doi:10.1038/srep12291.
   PubMed Web of Science ®Google Scholar
• Xia Y, Jiang L, Zhong T. The role of HIF-1alpha in chemo-/radioresistant tumors. Onco Targets Ther. 2018;11:3003–3011. doi:10.2147/OTT.S158206.
   PubMed Web of Science ®Google Scholar
• Hockel M, Vaupel P. Biological consequences of tumor hypoxia. Semin Oncol. 2001;28:36–41.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Hockel M. [Hypoxia in cervical cancer: pathogenesis, characterization, and biological/clinical consequences]. Zentralbl Gynakol. 2001;123:192–197. doi:10.1055/s-2001-14779.
   PubMedGoogle Scholar
• Shasha D. The negative impact of anemia on radiotherapy and chemoradiation outcomes. Semin Hematol. 2001;38:8–15. doi:10.1016/S0037-1963(01)90125-8.
   PubMed Web of Science ®Google Scholar